Eli Lilly and Company Plans to Lay Off 30 Pct of Its Sales Reps
Pharmaceutical giant Eli Lilly (LLY) plans reduce its U.S. sales group by nearly 1,000 representatives as part of a major restructuring, according to a report Thursday by Dow Jones Newswires. illy plans to add 300 diabetes sales jobs in addition to layoffs, bringing the net loss of sales representatives to less than 1,000 jobs.